Incidental gastrointestinal 18F-Fluorodeoxyglucose uptake associated with lung cancer.

Date publication

décembre 2015

Journal

BMC pulmonary medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier , Pr PAPATHANASSIOU Dimitri , Dr PREVOST Alain

Tous les auteurs :
Vella-Boucaud J, Papathanassiou D, Bouche O, Prevost A, Lestra T, Dury S, Vallerand H, Perotin JM, Launois C, Boissiere L, Brasseur M, Lebargy F, Deslee G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/26630933

Résumé

F-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) is increasingly used for the initial staging and restaging of lung cancer. Incidental gastrointestinal findings are often observed on (18)F-FDG PET/CT. The objective of this study was to assess incidental 18F-FDG uptake by the gastrointestinal tract (GIT) in patients with lung cancer.

Mots clés

Aged, Female, Fluorodeoxyglucose F18, metabolism, Gastrointestinal Tract, metabolism, Humans, Incidental Findings, Lung Neoplasms, diagnosis, Male, Middle Aged, Positron-Emission Tomography, Radiopharmaceuticals, metabolism, Retrospective Studies, Tomography, X-Ray Computed

Référence

BMC Pulm Med. 2015 Dec;15:152